Skip to content
Accessibility help

Search NICE…

Skip to content

Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About

Search results

Skip to results

Type

TypeGuidance (12)News (1)NICE advice (2)

Status

StatusIn development (1)Published (10)Topic selection (1)

Last updated

Last updatedLast 3 months (1)Last 6 months (1)Last year (1)Last 3 years (3)

Guidance programme

Guidance programmeTechnology appraisal guidance (12)

Advice programme

Advice programmeMedtech innovation briefings (2)

Showing 16 to 16 of 16 results for omalizumab

Sort by

SQ HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (review of TA834) [ID6280]
In development [GID-TA11355] Expected publication date: 09 July 2024
Result type
Technology appraisal guidance
Status
In development

Previous page
1
Current page 2
Page 2 of 2

Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Knowledge resources

About NICE
Into practice
Get involved with NICE
Jobs
News
Newsletters and alerts
Contact us
Leave feedback
Reusing our content
NICE UK Open Content Licence
Syndicate our content

Facebook
Twitter
YouTube
LinkedIn

Accessibility
Freedom of information
Glossary
Terms and conditions
Privacy notice
Cookies

© NICE 2024. All rights reserved. Subject to Notice of rights.